Home » EPIC Archives: OXB

OXB News Archives

Oxford BioMedica Eying up long-term value

Hardman & Co

Oxford BioMedica (OXB) is a specialist, advanced therapy, viral-vector biopharma company. It offers vector manufacturing and development services, while developing proprietary drug candidates, with its LentiVector® platform. 2018 saw significant ...

Read Article »

Oxford BioMedica De-leveraging the balance sheet

Hardman & Co

Oxford BioMedica (LON: OXB) is a specialist, advanced therapy, viral-vector biopharma company. It offers vector manufacturing and development services, while developing proprietary drug candidates, with its LentiVector® platform. 2018 saw ...

Read Article »